People take Adderall primarily to manage two medical conditions: attention deficit hyperactivity disorder (ADHD) and narcolepsy. A growing number also use it without a prescription, believing it will sharpen focus or boost academic and work performance. In 2023, roughly 16.5 million patients in the United States received a stimulant prescription, up 48% from 11.1 million in 2012, with Adderall accounting for about 49% of all stimulant prescriptions.
ADHD: The Most Common Reason
ADHD is the primary reason doctors prescribe Adderall. The condition involves persistent patterns of inattention, hyperactivity, or impulsivity that interfere with daily functioning at work, school, or home. Some people mainly struggle with focus: they lose things, miss details, can’t stick with tasks that require sustained mental effort, and get pulled off track easily. Others are more hyperactive or impulsive, fidgeting constantly, talking excessively, interrupting, or feeling like they’re always “on the go.” Many people have a combination of both.
For a long time, ADHD was thought of as a childhood condition. That perception has shifted dramatically. From 2012 to 2023, stimulant prescriptions increased 240% among adults aged 31 to 40, making that group the single largest age bracket for stimulant use. Prescriptions also rose 164% for people aged 41 to 50 and 161% for those 61 to 70. More adults are being diagnosed later in life after spending years developing workarounds for symptoms they didn’t realize had a name.
How Adderall Works in the Brain
Adderall is a mix of amphetamine salts that raises levels of dopamine and norepinephrine in the brain. For years, the assumption was that it primarily fixed “attention networks,” helping people filter distractions. Recent neuroscience research, including a 2025 study published in Cell, paints a more nuanced picture. Stimulant medications appear to shift the brain toward a more alert and reward-responsive state rather than directly sharpening attention circuits. They boost arousal through norepinephrine and enhance reward-motivated learning through dopamine, which makes effortful tasks feel less punishing.
This matters because one of the core struggles in ADHD isn’t simply an inability to pay attention. It’s that the brain’s reward system underperforms, making it genuinely harder to start, stick with, or finish tasks that don’t offer immediate payoff. Adderall doesn’t give people with ADHD superhuman focus. It moves their motivation and wakefulness closer to a baseline that most people take for granted, improving task persistence and follow-through.
Narcolepsy and Excessive Sleepiness
Adderall’s second approved use is narcolepsy, a neurological condition that causes overwhelming daytime sleepiness and, in some cases, sudden episodes of muscle weakness triggered by strong emotions. People with narcolepsy can fall asleep involuntarily during conversations, meals, or while driving.
Stimulants like Adderall improve alertness by increasing dopamine and, to a lesser degree, serotonin and norepinephrine. For narcolepsy, many people take a longer-acting form in the morning (sometimes again at midday) and add a shorter-acting dose before their worst sleepiness window, often in the late morning or afternoon. This layered approach helps maintain wakefulness across the day without a single large dose wearing off at the wrong time.
Off-Label Use for Cognitive Performance
Outside of these medical uses, Adderall has a well-known reputation as a “smart drug,” particularly on college campuses and in high-pressure professional settings. People without ADHD take it hoping to study longer, think faster, or power through deadlines. The belief is intuitive: if a stimulant helps people with attention problems focus, it should supercharge a brain that’s already functioning normally.
The evidence doesn’t support that assumption very well. A pilot study highlighted by the British Psychological Society found that Adderall offered limited cognitive benefits for healthy students and may actually impair working memory. The drug does reliably increase wakefulness and the subjective feeling of productivity, which is likely why users perceive it as helpful even when objective performance doesn’t improve. In other words, you may feel sharper without actually being sharper, while taking on the risks of a controlled substance.
What Taking Adderall Feels Like Day to Day
Both formulations kick in within 30 to 45 minutes. The immediate-release version lasts about 4 to 6 hours, meaning most people take it two or three times a day. The extended-release version (Adderall XR) lasts 8 to 12 hours and is designed so a single morning dose covers the workday or school day. Many people describe the effect as a quieting of mental noise: tasks that previously felt impossible to start become approachable, and the constant pull of distractions fades into the background.
The tradeoffs are real, though. Common side effects include reduced appetite, trouble sleeping (especially with afternoon doses), dry mouth, and increased heart rate. Some people feel jittery or notice their mood flattens. These effects vary widely from person to person and often improve after the first few weeks as the body adjusts.
Cardiovascular Risks and Long-Term Concerns
Because Adderall stimulates the same branch of the nervous system responsible for the “fight or flight” response, it can raise blood pressure and heart rate. A Cochrane review of clinical trials confirmed that stimulant medications are associated with increased pulse. Clinical guidelines recommend monitoring blood pressure and heart rate at baseline and at regular check-ins.
The question most long-term users care about is whether years of slightly elevated heart rate and blood pressure translate into real cardiovascular problems like heart attacks or strokes. A systematic review and meta-analysis in JAMA Network Open found that only two studies had sufficient follow-up time to examine this question, and both were of moderate quality. That means the honest answer is still uncertain. There’s a plausible biological mechanism for risk, but strong long-term data confirming or dismissing it doesn’t yet exist. People with pre-existing heart conditions face a more clearly elevated risk.
Supply Shortages and Access Challenges
If you’ve tried to fill an Adderall prescription in the past couple of years, you may have encountered empty shelves. Several manufacturers have reported shortages tied to a combination of active ingredient supply delays and surging demand. Some companies, including Mylan and Zydus, have discontinued their generic versions entirely. Others cite shipping delays or ingredient shortages. The CDC has issued a health advisory about disrupted access to prescription stimulants, noting potential increased risks for injury and overdose when patients can’t reliably access their medication.
The shortage has forced many patients to call multiple pharmacies, switch between brand and generic versions, or temporarily go without. For people who depend on Adderall to function at work or school, gaps in access can be destabilizing in ways that go well beyond inconvenience.